ARCHIVES

Lilly Made False Claims About Ralozifene Reducing Breast Cancer risk, Judge Rules

This article is from The Cancer Letter archive.

Vol. 25 No. 30 | July 30, 1999

Download PDF Visit The Full Archive

Related Articles

NCI T Use Ames Test In Carcinogenesis Testing Program

December 3, 1976

Ann Landers, Columnist Who Urged Support for Cancer Act, Dead

June 28, 2002

European Compound enhances IL-2 In BRMP Mouse Study; BRMP Mouse Study; Rosemberg Describes System Improvements, Updates Results

June 5, 1987

NCI Proposal Would Give Drug Sponsors Commercial Rights To Biomarker Inventions

October 16, 2009

Murphy Withdraws From SU Position

October 17, 1986

Major Changes In NCI Drug screening Tumor Panels Approved

June 18, 1982